Adial Pharmaceuticals (Adial Pharmaceuticals) Additional Paid-In Capital : $81.39 Mil(As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Adial Pharmaceuticals Additional Paid-In Capital?

Adial Pharmaceuticals's quarterly additional paid-in capital increased from Sep. 2023 ($69.22 Mil) to Dec. 2023 ($72.88 Mil) and increased from Dec. 2023 ($72.88 Mil) to Mar. 2024 ($81.39 Mil).

Adial Pharmaceuticals's annual additional paid-in capital increased from Dec. 2021 ($54.43 Mil) to Dec. 2022 ($66.95 Mil) and increased from Dec. 2022 ($66.95 Mil) to Dec. 2023 ($72.88 Mil).

Adial Pharmaceuticals Additional Paid-In Capital Historical Data

The historical data trend for Adial Pharmaceuticals's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adial Pharmaceuticals Additional Paid-In Capital Chart

Adial Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

27.76

35.49

54.43

66.95

72.88

Adial Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															67.99	68.81	69.22	72.88	81.39

Adial Pharmaceuticals Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Adial Pharmaceuticals Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Adial Pharmaceuticals's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Adial Pharmaceuticals (Adial Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adial Pharmaceuticals Inc (NAS:ADILW) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

ADIL:USA

Address

1180 Seminole Trail, Suite 495, Charlottesville, VA, USA, 22901

Website

https://www.adialpharma.com

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.